We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enhancing Anticancer Activity Through Computer Modeling

By LabMedica International staff writers
Posted on 27 May 2009
Print article
Cancer immunologists used a computer modeling system to predict and manipulate the cancer fighting ability of populations of tumor-infiltrating lymphocytes isolated from metastatic melanoma patients.

Tumor-infiltrating lymphocytes (TILs) are heterogeneous cell populations that form an interconnected network that determines their collective reactivity against tumors. TILs are used in adoptive cell transfer therapy, where they are removed from a metastatic melanoma patient's tumor and evaluated for their antitumor activity. TILs that show the strongest antitumor response are expanded and then reinjected back into the patient.

In the current study investigators at the Technion-Israel Institute of Technology (Haifa, Israel) sought to understand why some TILs possessed more potent anticancer potential than others. To this end they used flow cytometry measurements to establish the characteristics of the immune cells within 91 TILs removed from 27 metastatic melanoma patients. Results of this study showed that each TIL comprised several different subpopulations of immune cells, with each subpopulation distinguished by a particular set of chemical markers on the cell surfaces. This data enabled the investigators to develop a system of computational modeling that established a set of rules to predict which TILs would show the most antitumor activity based on their particular combination of subpopulations.

Information obtained from the modeling system enabled the investigators to prepare TILs that were particularly potent or particularly inactive. Results published in the April 28, 2009, online edition of the journal Molecular Systems Biology revealed that in 12 nonreactive TILs taken from four patients, the investigators were able to induce a 106-fold increase in TIL antitumor activity by expanding an optimal blend of subpopulations within the TIL.

"The computational tools we developed allowed us to predict whether a TIL culture will respond to the tumor with an accuracy of more than 90%," said senior author Dr. Yoram Reiter, professor of biology at the Technion. "This enabled us to turn nonreactive TILs into reactive ones and vice versa. We need to expand the samples that we have tested from more patients, followed by more examples on TIL cultures that can be transformed from nonreactive to reactive."

Related Links:
Technion-Israel Institute of Technology


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.